WallStreetZenWallStreetZen

NASDAQ: OPK
Opko Health Inc Stock

$1.45+0.05 (+3.57%)
Updated Jun 2, 2023
OPK Price
$1.45
Fair Value Price
$1.65
Market Cap
$1.12B
52 Week Low
$1.00
52 Week High
$3.06
P/E
-3.72x
P/B
0.72x
P/S
1.2x
PEG
N/A
Dividend Yield
N/A
Revenue
$912.55M
Earnings
-$291.24M
Gross Margin
33.1%
Operating Margin
-35.01%
Profit Margin
-31.9%
Debt to Equity
0.4
Operating Cash Flow
-$98M
Beta
1.23
Next Earnings
Aug 2, 2023
Ex-Dividend
N/A
Next Dividend
N/A

OPK Overview

OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional healthcare to physician offices, clinics, hospitals, employers and governmental units; and a novel diagnostic instrument system to provide blood test results in the point-of-care setting, as well as 4Kscore prostate cancer testing services. Its Pharmaceutical segment offers Rayaldee to treat secondary hyperparathyroidism in adults with stage 3 or 4 chronic kidney disease, and vitamin D insufficiency; OPK88004, an orally administered selective androgen receptor modulator; OPK88003, a once-weekly administered peptide for the treatment of type 2 diabetes and associated obesity that is in Phase IIb trials; and hGH-CTP, a once-weekly human growth hormone injection that completed Phase III clinical trial in partnership with Pfizer, Inc. This segment develops and commercializes longer-acting proprietary versions of already approved therapeutic proteins. The company also offers specialty APIs; develops, manufactures, markets, and sells pharmaceutical, nutraceutical, veterinary, and ophthalmic products; commercializes food supplements and over the counter products; manufactures and sells products primarily in the generics market; and imports, markets, distributes, and sells pharmaceutical products in a range of indications, including cardiovascular products, vaccines, antibiotics, gastro-intestinal products, hormones, and others. In addition, it operates pharmaceutical platforms in Ireland, Chile, Spain, and Mexico. The company was founded in 1991 and is headquartered in Miami, Florida.

Zen Score

Industry Average (28)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how OPK scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

OPK ($1.45) is undervalued by 12.34% relative to our estimate of its Fair Value price of $1.65 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
OPK ($1.45) is not significantly undervalued (12.34%) relative to our estimate of its Fair Value price of $1.65 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
OPK is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more OPK due diligence checks available for Premium users.

Be the first to know about important OPK news, forecast changes, insider trades & much more!

Valuation

OPK fair value

Fair Value of OPK stock based on Discounted Cash Flow (DCF)
Price
$1.45
Fair Value
$1.65
Undervalued by
12.34%
OPK ($1.45) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
OPK ($1.45) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
OPK is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

OPK price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-3.72x
Industry
31.67x
Market
52.69x

OPK price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.72x
Industry
4.02x
OPK is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

OPK's financial health

Profit margin

Revenue
$237.6M
Net Income
-$18.3M
Profit Margin
-7.7%
OPK's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
OPK's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$2.2B
Liabilities
$617.9M
Debt to equity
0.4
OPK's short-term assets ($406.42M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
OPK's short-term assets ($406.42M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
OPK's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
OPK's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$22.6M
Investing
-$7.7M
Financing
-$13.1M
OPK's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

OPK vs Diagnostic & Research Stocks

TickerMarket Cap1d %P/EP/B
OPK$1.12B+3.57%-3.72x0.72x
NRC$1.12B+4.05%37.46x15.06x
FLGT$1.20B-0.91%-47.45x0.95x
ME$945.57M+3.54%-2.97x1.32x
HSKA$1.31B-0.01%-62.42x3.13x

Opko Health Stock FAQ

What is Opko Health's quote symbol?

(NASDAQ: OPK) Opko Health trades on the NASDAQ under the ticker symbol OPK. Opko Health stock quotes can also be displayed as NASDAQ: OPK.

If you're new to stock investing, here's how to buy Opko Health stock.

What is the 52 week high and low for Opko Health (NASDAQ: OPK)?

(NASDAQ: OPK) Opko Health's 52-week high was $3.06, and its 52-week low was $1.00. It is currently -52.61% from its 52-week high and 45% from its 52-week low.

How much is Opko Health stock worth today?

(NASDAQ: OPK) Opko Health currently has 772,650,812 outstanding shares. With Opko Health stock trading at $1.45 per share, the total value of Opko Health stock (market capitalization) is $1.12B.

Opko Health stock was originally listed at a price of $6.88 in Dec 31, 1997. If you had invested in Opko Health stock at $6.88, your return over the last 25 years would have been -78.91%, for an annualized return of -6.04% (not including any dividends or dividend reinvestments).

How much is Opko Health's stock price per share?

(NASDAQ: OPK) Opko Health stock price per share is $1.45 today (as of Jun 2, 2023).

What is Opko Health's Market Cap?

(NASDAQ: OPK) Opko Health's market cap is $1.12B, as of Jun 5, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Opko Health's market cap is calculated by multiplying OPK's current stock price of $1.45 by OPK's total outstanding shares of 772,650,812.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.